Stock Scorecard



Stock Summary for Vaxart Inc (VXRT) - $0.42 as of 3/31/2025 2:55:58 PM EST

Total Score

11 out of 30

Safety Score

19 out of 100

Currently on the following lists
None
Tim's Recommendation
Avoid

Growth List Algorithm Criteria for VXRT

Positive earnings growth
P/E ratio less than Industry P/E Ratio
P/E ratio less than Sector P/E Ratio
P/E ratio that is half the growth rate (or less)
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Positive net income past year and 12 trailing months
Free cash flow ratio greater than 0 and less than 10

Small Cap List Algorithm Criteria for VXRT

Revenue growing by at least 20% average per year over the last 5 years
Market Capitalization under 2 billion
Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months
Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months
Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year

Dividend List Algorithm Criteria for VXRT

Declared an ex-dividend date
Forward annual dividend rate greater than 2
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Current ratio most recent quarter greater than 2
Cash Flow per Share greater than Trailing Dividend Rate

Bonus Criteria for VXRT

P/E ratio less than five-year Average P/E ratio
Last Price to 52 Week Low Ratio Less Than 1
Total Cash Per Share > Last Day Price
P/S Ratio < 1
P/B Ratio < 1

Safety Rating Criteria for VXRT (19 out of 100)

Stock Price Rating (Max of 10) 1
Historical Stock Price Rating (Max of 10) 4
Stock Price Trend (Max of 10) 1
Book Value (Max of 10) 1
Book Value to Price (Max of 10) 0
Analyst Buy Ratings (Max of 5) 3
Analyst Strong Buy Ratings (Max of 5) 0
Dividend Yield Percentage (Max of 10) 0
Operating Margin (Max of 10) 0
Trading Volume (Max of 10) 9
Price to Earnings (Max of 10) 0
Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) 0

Latest News for for VXRT

VAXART, INC. ( VXRT ) Reports Q4 Loss, Lags Revenue Estimates 3/20/2025 9:15:00 PM
Vaxart to Host Full Year 2024 Business Update and Financial Results Conference Call on March 20 3/13/2025 12:00:00 PM
ElectroCore, Inc. ( ECOR ) Reports Q4 Loss, Lags Revenue Estimates 3/12/2025 9:15:00 PM
Xeris Biopharma ( XERS ) Reports Q4 Loss, Misses Revenue Estimates 3/6/2025 1:15:00 PM
Vaxart Announces Publication Demonstrating the Immunogenicity and Safety of its First-Generation Oral Pill Norovirus Vaccine Candidate in Elderly Adults - Vaxart ( NASDAQ:VXRT ) 3/5/2025 9:05:00 PM
Cronos Group ( CRON ) Reports Q4 Loss, Misses Revenue Estimates 2/27/2025 1:50:00 PM
Viral Vaccines Market Size is Projected to Reach USD 93.42 Billion by 2033, Growing at a CAGR of 8.4%: Straits Research 2/3/2025 2:19:00 PM
Vaxart Announces Favorable DSMB Review of Sentinel Cohort from COVID-19 Phase 2b Clinical Trial 1/14/2025 12:55:00 AM
Vaxart Completes Enrollment of Sentinel Cohort in Phase 2b Study Evaluating Its COVID-19 Oral Pill Vaccine Candidate - Vaxart ( NASDAQ:VXRT ) 12/2/2024 9:01:00 PM
VAXART, INC. ( VXRT ) Reports Q3 Loss, Tops Revenue Estimates 11/13/2024 10:20:00 PM

Financial Details for VXRT

Company Overview

Ticker VXRT
Company Name Vaxart Inc
Country USA
Description Vaxart, Inc., a clinical-stage biotechnology company, is dedicated to the discovery and development of oral recombinant protein vaccines based on its proprietary oral vaccine platform. The company is headquartered in South San Francisco, California.
Sector Name LIFE SCIENCES
Industry Name BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Most Recent Quarter 12/31/2024
Next Earnings Date 5/12/2025

Stock Price History

Last Day Price 0.42
Price 4 Years Ago 6.27
Last Day Price Updated 3/31/2025 2:55:58 PM EST
Last Day Volume 1,923,798
Average Daily Volume 2,078,857
52-Week High 1.34
52-Week Low 0.45
Last Price to 52 Week Low 6.67%

Valuation Measures

Trailing PE N/A
Industry PE 53.93
Sector PE 40.10
5-Year Average PE -6.24
Free Cash Flow Ratio 1.62
Industry Free Cash Flow Ratio 18.14
Sector Free Cash Flow Ratio 47.05
Current Ratio Most Recent Quarter 0.83
Total Cash Per Share 0.26
Book Value Per Share Most Recent Quarter 0.26
Price to Book Ratio 1.77
Industry Price to Book Ratio 11.03
Sector Price to Book Ratio 21.92
Price to Sales Ratio Twelve Trailing Months 3.69
Industry Price to Sales Ratio Twelve Trailing Months 59.91
Sector Price to Sales Ratio Twelve Trailing Months 27.78
Analyst Buy Ratings 3
Analyst Strong Buy Ratings 0

Share Statistics

Total Shares Outstanding 227,949,000
Market Capitalization 95,738,580
Institutional Ownership N/A

Dividends

Ex-Dividend Date 11/9/2012
Previous Dividend Amount 0.0000
Current Dividend Amount 73.1279
Total Years Dividend Increasing 0
Trailing Annual Dividend Rate 0.00
Trailing Annual Dividend Yield 0.00%
Forward Annual Dividend Rate 0.00
Forward Annual Dividend Yield 0.00%
5-Year Dividend Payments Count 0
3-Year Average Dividend Yield 0.00%
5-Year Average Dividend Yield 0.00%
1-Year Dividend Growth Rate Percentage 0.00%
3-Year Dividend Growth Rate Percentage 0.00%
5-Year Dividend Growth Rate Percentage 0.00%
All-Time Dividend Growth Rate Percentage 0.00%
Dividend Payout Ratio N/A

Income Statement

Quarterly Earnings Growth YOY 0.00%
Annual Earnings Growth 23.47%
Reported EPS 12 Trailing Months -0.32
Reported EPS Past Year -0.34
Reported EPS Prior Year -0.58
Net Income Twelve Trailing Months -72,338,000
Net Income Past Year -82,465,000
Net Income Prior Year -107,758,000
Quarterly Revenue Growth YOY 368.00%
5-Year Revenue Growth 11.79%
Operating Margin Twelve Trailing Months -75.70%

Balance Sheet

Total Cash Most Recent Quarter 58,700,000
Total Cash Past Year 39,700,000
Total Cash Prior Year 95,700,000
Net Cash Position Most Recent Quarter 58,700,000
Net Cash Position Past Year 39,700,000
Long Term Debt Past Year 0
Long Term Debt Prior Year 0
Total Debt Most Recent Quarter 0
Equity to Debt Ratio Past Year 1.00
Equity to Debt Ratio Most Recent Quarter 1.00
Total Stockholder Equity Past Year 57,805,000
Total Stockholder Equity Prior Year 110,597,000
Total Stockholder Equity Most Recent Quarter 68,442,000

Free Cash Flow

Free Cash Flow Twelve Trailing Months -51,346,000
Free Cash Flow Per Share Twelve Trailing Months -0.23
Free Cash Flow Past Year -72,324,000
Free Cash Flow Prior Year -104,380,000

Options

Put/Call Ratio 0.00
Has Options Options Chain
Liquidity Rating

Technical Analysis

Yahoo Finance Chart Yahoo Finance Chart
MACD -0.03
MACD Signal -0.03
20-Day Bollinger Lower Band 0.42
20-Day Bollinger Middle Band 0.64
20-Day Bollinger Upper Band 0.87
Beta 1.70
RSI 37.79
50-Day SMA 0.73
150-Day SMA 1.23
200-Day SMA 2.55

System

Modified 3/28/2025 10:50:22 AM EST